Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Acura Pharmaceuticals Inc. (ACUR)

0.322   -0.026 (-7.47%) 07-02 15:33
Open: 0.28 Pre. Close: 0.348
High: 0.35 Low: 0.28
Volume: 3,645 Market Cap: 7M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.35 - 0.353 0.353 - 0.355
Low: 0.275 - 0.278 0.278 - 0.279
Close: 0.316 - 0.321 0.321 - 0.324

Technical analysis

as of: 2020-07-02 4:27:10 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 0.41     One year: 0.46
Support: Support1: 0.28    Support2: 0.23
Resistance: Resistance1: 0.35    Resistance2: 0.39
Pivot: 0.32
Moving Average: MA(5): 0.34     MA(20): 0.32
MA(100): 0.31     MA(250): 0.31
MACD: MACD(12,26):     Signal(9):
Stochastic oscillator: %K(14,3): 85.71     %D(3): 90.16
RSI: RSI(14): 49.42
52-week: High: 0.63  Low: 0.12  Change(%): 40.0
Average Vol(K): 3-Month: 1303  10-Days: 654

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ACUR has closed above bottom band by 49.1%. Bollinger Bands are 37.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 30 Jun 2020
ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K Results of Operations and Financial Condition - Market Exclusive

Mon, 29 Jun 2020
Acura Pharmaceuticals Announces First Quarter 2020 Financial Results Other OTC:ACUR - GlobeNewswire

Mon, 23 Mar 2020
Acura Pharmaceuticals Provides an Update on the Development of LTX-03 - GlobeNewswire

Fri, 28 Feb 2020
Acura Pharmaceuticals Announces Third Quarter 2019 Financial Results Other OTC:ACUR - GlobeNewswire

Mon, 10 Feb 2020
Acura Pharmaceuticals Announces Second Quarter 2019 Financial Results Other OTC:ACUR - GlobeNewswire

Thu, 19 Dec 2019
ACUR | Acura Pharmaceuticals Inc. Stock Price & News - WSJ - Wall Street Journal

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange: 
Sector: 
Industry: 
Shares Out. (M) 22
Shares Float (M) 7
% Held by Insiders 52.81
% Held by Institutions 9.05
Shares Short (K) 90
Shares Short P. Month (K) 76

Stock Financials

EPS -0.141
EPS Est This Year -0.460
EPS Est Next Year 0.370
Book Value (p.s.) -0.220
Profit Margin -142.04
Operating Margin -27.29
Return on Assets (ttm) -19.2
Return on Equity (ttm)
Qtrly Rev. Growth 1836.5
Gross Profit (p.s.) 0.053
Sales Per Share 0.123
EBITDA (p.s.) -0.021
Qtrly Earnings Growth 1837.50
Operating Cash Flow (M) -1
Levered Free Cash Flow (M) -1

Stock Valuations

PE Ratio -2.28
PEG Ratio
Price to Book value -1.46
Price to Sales 2.62
Price to Cash Flow -11.28

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.